KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Johnson & Johnson's Shares Outstanding (Weighted Average) changed 0.42% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year change of 0.42%. This contributed to the annual value of $2.4 billion for FY2025, which is 0.42% changed from last year.
  • According to the latest figures from Q4 2025, Johnson & Johnson's Shares Outstanding (Weighted Average) is $2.4 billion, which was up 0.42% from $2.4 billion recorded in Q3 2025.
  • Over the past 5 years, Johnson & Johnson's Shares Outstanding (Weighted Average) peaked at $2.6 billion during Q1 2021, and registered a low of $2.4 billion during Q2 2025.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $2.5 billion, with a median of $2.6 billion in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 757.24% in 2024, then rose by 3.74% in 2025.
  • Quarter analysis of 5 years shows Johnson & Johnson's Shares Outstanding (Weighted Average) stood at $2.6 billion in 2021, then dropped by 0.14% to $2.6 billion in 2022, then decreased by 3.63% to $2.5 billion in 2023, then dropped by 4.98% to $2.4 billion in 2024, then rose by 0.0% to $2.4 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $2.4 billion for Q4 2025, versus $2.4 billion for Q3 2025 and $2.4 billion for Q2 2025.